Skip to main content
Premium Trial:

Request an Annual Quote

Compugen s Q1 Revenue Slides By Nearly Half Though Loss Narrows

NEW YORK, April 27 (GenomeWeb News) - Compugen today said that first-quarter revenue declined 58 percent as R&D spending decreased 22 percent and net losses shrank 19 percent.

 

Total receipts for the three months ended March 31 slipped to $200,000 from $481,000 in the year-ago period. Compugen said the decrease is "in line with [its] evolution to utilizing its scientific know-how and computational biology capabilities for the discovery of potential therapeutic and diagnostic products."

 

In a statement, Compugen said it has previously said that its "anticipated primary sources of future revenues" are milestone and revenue-sharing payments from licensing and other arrangements "covering the development and marketing of diagnostic and therapeutic products based on the [its] discoveries.

 

"Compugen anticipates that it will begin to receive such payments from its existing arrangements by the end of this year or early next year, and these revenues are anticipated to increase substantially in the following years as products based on Compugen-discovered molecules progress towards commercialization," the company said in the statement.

 

R&D spending for the quarter fell to $2.7 million from $3.5 million.

 

Net losses narrowed to $3 million, or $.11 per share, from $3.7 million, or $.13 per share, year over year.

 

Compugen said it had around $33.8 million in cash, equivalents, and marketable securities as of March 31.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.